Please login to the form below

Not currently logged in
Email:
Password:

tisagenleucel

This page shows the latest tisagenleucel news and features for those working in and with pharma, biotech and healthcare.

Axovant bets on gene therapy with $842.5m Oxford BioMedica deal

Axovant bets on gene therapy with $842.5m Oxford BioMedica deal

tisagenleucel). Axovant CEO Pavan Cheruvu, who took the helm of the company after David Hung and other senior execs resigned in the wake of the intepirdine failure, said the company will

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....